CBD expansion: Aussie pharma firm outlines Asia nutraceutical plans after China launch

By Cheryl Tay

11-Jun-2019 - Last updated on 11-Jun-2019 at 04:16 GMT

Australian bio-pharmaceutical firm MGC Pharmaceuticals is eyeing expansion in East and South East Asia with its cannabis-based nutraceutical products, after having recently launched in China.

Read the full story here.

Top 10 stories (May 2019

CBD expansion: Aussie pharma firm outlines Asia nutraceutical plans after China launch

Driving India's nutraceutical growth: New trade body launches website and names advocacy boards

Bill Gates-backed probiotic firm Evolve BioSystems makes APAC debut with Singapore, Hong Kong launch

Personalised gummies for skin health: Chinese skincare brand expands into nutrition with beauty-from-within range

From buns to bacteria: 'First-of-its-kind' probiotic facility opens in Australia following Chinese investment

Success from specialisation: Nestlé China attributes growth to organic, A2 and special care infant nutrition NPD

Imports still impress: Survey reveals Chinese consumers place premium on overseas supplements

Aussie exporter eyes China and wider APAC region with new in-house functional food and supplements

Regulatory Review: Dairy ban and diet pills in India, health claims in Singapore, and Nestlé's infant formula controversy

Nature's Care unfazed by China's new CBEC laws, with strong growth spurring confidence after $563m takeover

Related news

Show more

Related products

show more

Whitepaper: Discover a new era in postbiotics

Content provided by DSM Nutritional Products | 28-Nov-2023 | White Paper

Postbiotic ingredients are set to open up a world of opportunities across the human health and nutrition industry, fueled by developing science demonstrating...

Taking Immune Support to a New Level

Content provided by AB Biotek Human Nutrition & Health | 30-Oct-2023 | White Paper

Patent-pending ABB C1® redefines immune support by addressing innate, acquired, and Trained Immunity. In 'ABB C1®: Training Now for Future Immune...

Pycnogenol®: The Clinically Evidenced Skincare Ingredient

Content provided by Horphag Research | 25-Oct-2023 | Application Note

Pycnogenol® has 25+ clinical studies demonstrating its active properties for oral and topical skincare formulations.

Gencor Pacific Limited

Content provided by Gencor | 05-Oct-2023 | Product Brochure

In a recent clinical trial backing its ingredient Libifem® for improved muscle strength, power, endurance and body composition with a females-only popluation...

Related suppliers

Kerry

Follow us

Products

View more

Webinars

On-demand webinars

Nutra Champions Podcast

Nutra Champions Podcast

Headlines

Promotional Features